+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

EF1A1-actin interactions alter mRNA stability to determine differential osteopontin expression in HepG2 and Hep3B cells



EF1A1-actin interactions alter mRNA stability to determine differential osteopontin expression in HepG2 and Hep3B cells



Experimental Cell Research 315(2): 304-312



Cancer progression depends on an accumulation of metastasis-supporting physiological changes which are regulated by cell signaling molecules. One such molecule, osteopontin (OPN), is a secreted phosphoprotein which mediates increased cellular migratory and invasive behavior, increased metastasis, protection from apoptosis, promotion of colony formation and 3D growth ability, induction of tumor-associated inflammatory cells, and induction of expression of angiogenic factors. Studies show that OPN expression is controlled by complex regulatory pathways at the transcriptional level in several cancers, but the molecular mechanisms which determine expression of OPN in HCC are largely unknown. In HepG2 and Hep3B tumor cell lines that differentially express OPN mRNA and protein, we identify elongation translation factor-1A1 (EF1A1) to be the trans-acting factor regulating differential OPN mRNA stability between HepG2 and Hep3B cell lines and characterize its interactions with G- and F-actin. EF1A1 binds to the OPN 5'-UTR to regulate OPN mRNA half-life. EF1A1 binds to actin in Hep3B cells. Pharmacologic manipulation to increase the G:F actin ratio in Hep3B increases OPN mRNA half-life and protein expression with simultaneous decrease in EF1A1 binding to OPN 5'-UTR. The converse findings were noted in HepG2 cells. Overall, our results suggest that EF1A1 regulation of OPN mRNA stability is actin dependent. EF1A1 has not been previously identified as a regulatory factor in OPN expression in cancer.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 024520460

Download citation: RISBibTeXText

PMID: 19026636

DOI: 10.1016/j.yexcr.2008.10.042


Related references

Differential expression of sub-proteome between human liver cancer HepG2 and Hep3B cell lines. Molecular & Cellular Proteomics 1(9): 675, 2002

Protein-PTH mRNA interactions that determine PTH mRNA stability in secondary hyper- and hypoparathyroidism. 2007

Effect of ischemia post-conditioning on skeletal muscle oxidative injury, mTOR, Bax, Bcl-2 proteins expression, and HIF-1α/β-actin mRNA, IL-6/β-actin mRNA and caveolin-3/β-actin mRNA expression in ischemia-reperfusion rabbits. Molecular Biology Reports 40(1): 507-514, 2013

Differential expression patterns of beta-actin mRNA in cells undergoing apoptosis. Biochemical and Biophysical Research Communications 211(2): 491-496, 1995

Osteopontin-dependent CD44v6 expression and cell adhesion in HepG2 cells. Carcinogenesis 24(12): 1871-1878, 2003

Differential expression of alpha-actin mRNA and immunoreactive protein in brain microvascular pericytes and smooth muscle cells. Journal of Neuroscience Research 39(4): 430-435, 1994

Expression of transforming growth factor-beta 1 mRNA and osteopontin mRNA in UMR-106 cells under mechanical stimulation. Zhonghua Kou Qiang Yi Xue Za Zhi 35(1): 27-30, 2002

Differential expression of osteopontin, PC4, and CEC5, a novel mRNA species, during in vitro angiogenesis. Experimental Cell Research 239(1): 1-10, 1998

Differential expression and stability of poly(ADP-ribose)polymerase mRNA in human cells. Biochimica et Biophysica Acta 1173(2): 133-140, 1993

Nitric oxide-dependent osteopontin expression induces metastatic behavior in HepG2 cells. Digestive Diseases and Sciences 50(7): 1288-1298, 2005

EGF/PI3K signaling pathway regulates the expression of osteopontin in liver cancer HepG2 cells. Zhonghua Yi Xue Za Zhi 83(22): 1980-1983, 2004

Estrogenic and antiestrogenic non-steroidal xenobiotics alter the stability of apolipoprotein II mRNA in the avian liver by modulating the hepatic expression of the estrogen-regulated mRNA stabilizing factor. FASEB Journal 10(3): A459, 1996

Differential effect of platelet-derived growth factor- versus serum-induced growth on smooth muscle a-actin and nonmuscle b-actin mRNA expression in cultured rat aortic smooth muscle cells. The Journal of Biological Chemistry 264: 501-6, 1989

Decreased ABCB1 mRNA expression induced by atorvastatin results from enhanced mRNA degradation in HepG2 cells. European Journal of Pharmaceutical Sciences 37(3-4): 486-491, 2009

Differential effect of platelet-derived growth factor- versus serum-induced growth on smooth muscle alpha-actin and nonmuscle beta-actin mRNA expression in cultured rat aortic smooth muscle cells. Journal of Biological Chemistry 264(18): 10501-6, 1989